Vincerx Pharma (VINC) Expected to Announce Earnings on Friday

Vincerx Pharma (NASDAQ:VINC) is projected to release its earnings data before the market opens on Friday, April 4th. Analysts expect Vincerx Pharma to post earnings of ($2.60) per share for the quarter.

Vincerx Pharma Trading Down 6.0 %

Shares of VINC stock opened at $0.57 on Friday. The firm’s fifty day moving average price is $1.28 and its two-hundred day moving average price is $5.33. Vincerx Pharma has a 1 year low of $0.49 and a 1 year high of $136.80. The firm has a market capitalization of $1.27 million, a P/E ratio of -0.03 and a beta of 1.43.

About Vincerx Pharma

Vincerx Pharma, Inc, a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors.